Literature DB >> 7002738

Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance.

P Kurki, A Miettinen, E Linder, P Pikkarainen, M Vuoristo, M P Salaspuro.   

Abstract

The diagnostic and prognostic significance of the different types of serum smooth muscle antibodies (SMA) were investigated in sera of 24 patients with chronic active hepatitis (CAH) and 15 patients with primary biliary cirrhosis (PBC). SMA of IgG class were found in 92% of sera from patients with CAH but in only 20% of sera from PBC patients, whereas the incidence of IgM-SMA was higher in PBC (67%) than in CAH (38%). All six patients with the atypical cholestatic form of CAH has SMA of IgM class, whereas other CAH patients had SMA of mainly IgG class. SMA reacting with rabbit liver (bile canaliculus antibodies, BCA) and with rat glomeruli (glomerulus antibodies) were of anti-actin specificity and were more common in CAH than in PBC. Organ specific BCA or glomerulus antibodies were not found. Anti-actin antibodies were detected in the majority of the investigated sera by an immunoenzymatic anti-actin assay. The results suggest that the determination of SMA titres with heavy chain specific antisera may help in the assessment of diagnosis and prognosis of chronic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002738      PMCID: PMC1419380          DOI: 10.1136/gut.21.10.878

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  The presentation and diagnosis of 100 patients with primary biliary cirrhosis.

Authors:  S Sherlock; P J Scheuer
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

2.  Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells.

Authors:  S Whittingham; I R Mackay; J Irwin
Journal:  Lancet       Date:  1966-06-18       Impact factor: 79.321

3.  High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis.

Authors:  R M Galbraith; M Smith; R M Mackenzie; D E Tee; D Doniach; R Williams
Journal:  N Engl J Med       Date:  1974-01-10       Impact factor: 91.245

4.  Bile canalicular antibody in primary biliary cirrhosis and in other liver diseases.

Authors:  R N MacSween; E M Armstrong; K G Gray; M Mason
Journal:  Lancet       Date:  1973-06-23       Impact factor: 79.321

5.  Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease.

Authors:  F J Dudley; M J O'Shea; A Ajdukiewicz; S Sherlock
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

6.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

7.  Hetero-antibody against bile canaliculi in patients with chronic, clinically active hepatitis.

Authors:  H Diederichsen
Journal:  Acta Med Scand       Date:  1969-10

8.  Australia antigen and circulating antibodies in chronic aggressive hepatitis.

Authors:  J Findor; E B Igartua; A Alonso; R Domecq; C Bozzola
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1973 Mar-Apr

9.  Anticomplementary hepatitis B antigen. Prognostic importance in chronic active liver disease.

Authors:  G L Gitnick; W H Summerskill; R D Soloway; S Ritman; L J Schoenfield
Journal:  Arch Intern Med       Date:  1973-10

10.  Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells.

Authors:  G Gabbiani; G B Ryan; J P Lamelin; P Vassalli; G Majno; C A Bouvier; A Cruchaud; E F Lüscher
Journal:  Am J Pathol       Date:  1973-09       Impact factor: 4.307

View more
  4 in total

1.  Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases: a comparison of classical indirect immunofluorescence with ELISA.

Authors:  A Zamanou; A Tsirogianni; C Terzoglou; A Balafas; I Economidou; P Lymberi
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

2.  Immunohistochemical localization of human liver specific protein using rabbit antisera and the avidin-biotin complex technique.

Authors:  H Helin; R Uibo; I Paronen; K Krohn
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

Review 3.  Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases.

Authors:  Birgit Terjung; Ulrich Spengler
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

4.  Cloning from the thyroid of a protein related to actin binding protein that is recognized by Graves disease immunoglobulins.

Authors:  P J Leedman; B Faulkner-Jones; D S Cram; P J Harrison; J West; E O'Brien; R Simpson; R L Coppel; L C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.